These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33015679)

  • 1. BCG vaccination: An update on current Australian practices.
    Taylor JW; Curtis N; Denholm J
    Aust J Gen Pract; 2020 Oct; 49(10):651-655. PubMed ID: 33015679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
    Faust L; Schreiber Y; Bocking N
    BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.
    Hesseling AC; Rabie H; Marais BJ; Manders M; Lips M; Schaaf HS; Gie RP; Cotton MF; van Helden PD; Warren RM; Beyers N
    Clin Infect Dis; 2006 Feb; 42(4):548-58. PubMed ID: 16421800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disseminated bacille Calmette-Guérin disease in Saudi children: clinical profile, microbiology, immunology evaluation and outcome.
    Bukhari E; Alaklobi F; Bakheet H; Alrabiaah A; Alotibi F; Aljobair F; Alshamrani M; Alaki E; Alnahdi F; Alodyani A; Alzamil F
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3696-702. PubMed ID: 27649674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The BCG vaccine: information and recommendations for use in Australia.
    National Tuberculosis Advisory Committee
    Commun Dis Intell Q Rep; 2006; 30(1):109-15. PubMed ID: 16637239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated Bacille Calmette-Guerin (BCG) disease in an infant with severe combined immunodeficiency.
    Sohail S; Afzal M; Anwar V; Shama Q
    J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S259-61. PubMed ID: 25518795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
    Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
    BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.
    Hesseling AC; Marais BJ; Gie RP; Schaaf HS; Fine PE; Godfrey-Faussett P; Beyers N
    Vaccine; 2007 Jan; 25(1):14-8. PubMed ID: 16959383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCG vaccination strategies against tuberculosis: updates and perspectives.
    Qu M; Zhou X; Li H
    Hum Vaccin Immunother; 2021 Dec; 17(12):5284-5295. PubMed ID: 34856853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of Bacille Calmette Guérin (BCG) immunisation in Europe - A ptbnet survey and review of current guidelines.
    Dierig A; Tebruegge M; Krivec U; Heininger U; Ritz N;
    Vaccine; 2015 Sep; 33(38):4994-9. PubMed ID: 26151543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates.
    Franco-Paredes C; Rouphael N; del Rio C; Santos-Preciado JI
    Int J Infect Dis; 2006 Mar; 10(2):93-102. PubMed ID: 16377228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of the Polish BCG-10 Vaccine During a Period of BCG Vaccine Shortage: An Australian Experience.
    Wong NX; Buttery J; McMinn A; Azhar Z; Crawford NW
    Pediatr Infect Dis J; 2020 Jun; 39(6):e66-e68. PubMed ID: 32150004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
    Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
    BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors associated with latent tuberculosis infection in Mexican American children.
    Young J; O'Connor ME
    Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.